Proximal femoral fracture
Conditions
Interventions
In the addition group: dexamethasone (Orgadrone Injection) 3.8mg(1ml) is added to the drug solution used for the previous FICB at our institution.
In the control group: FICB is performed as before.
Sponsors
Shimura Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients who will be underwent proximal femoral fracture surgery under general anesthesia combined with ultrasound-guided FICB at our facility. 2.Subjects who can make self-judgment and are voluntarily giving written informed consent.
Exclusion criteria
Exclusion criteria: 1.Patients who cannot complain of pain or patients who cannot administer NSAIDs or acetaminophen 2.Patients who received NSAIDs or acetaminophen within 3 hours before entering the operating room to immediately after surgery 3.Subjects who have diabetes or prone to infections 4.Others who have been determined ineligible by principal investigator or sub-investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration from FICB administration to first as-needed analgesic administration | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of doses of as-needed analgesics (within 48 hours from FICB) Safety evaluation items: Vital sign changes such as postoperative hypotension (within 48 hours from FICB) Prolongation of motor block of the affected limb (within 48 hours from FICB) Local infection (within 1 week after surgery) | — |
Countries
Japan
Contacts
Public ContactShima Taguchi
Shimura Hospital Department of Anesthesiology
Outcome results
None listed